Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OPTIMARK Cause Nephrogenic systemic fibrosis? 121 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Nephrogenic systemic fibrosis have been filed in association with OPTIMARK. This represents 97.6% of all adverse event reports for OPTIMARK.

121
Reports of Nephrogenic systemic fibrosis with OPTIMARK
97.6%
of all OPTIMARK reports
15
Deaths
4
Hospitalizations

How Dangerous Is Nephrogenic systemic fibrosis From OPTIMARK?

Of the 121 reports, 15 (12.4%) resulted in death, 4 (3.3%) required hospitalization.

Is Nephrogenic systemic fibrosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OPTIMARK. However, 121 reports have been filed with the FAERS database.

What Other Side Effects Does OPTIMARK Cause?

What Other Drugs Cause Nephrogenic systemic fibrosis?

OMNISCAN (658) GADOLINIUM (370) MAGNEVIST (322) GADODIAMIDE (99) PROHANCE (85) MULTIHANCE (77) GADOPENTETATE DIMEGLUMINE (60) GADOTERATE MEGLUMINE (36) GADOBENATE DIMEGLUMINE (35) GADOTERIDOL (31)

Which OPTIMARK Alternatives Have Lower Nephrogenic systemic fibrosis Risk?

OPTIMARK vs OPTIRAY OPTIMARK vs ORELABRUTINIB OPTIMARK vs ORENCIA OPTIMARK vs ORITAVANCIN OPTIMARK vs ORITAVANCIN DIPHOSPHATE

Related Pages

OPTIMARK Full Profile All Nephrogenic systemic fibrosis Reports All Drugs Causing Nephrogenic systemic fibrosis OPTIMARK Demographics